Noven Pharmaceuticals Inc

Type: Company
Name: Noven Pharmaceuticals Inc
Nationality: United States
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Noven Pharmaceuticals Assigned Patent for Multi-layer Transdermal Drug Delivery Device

By Targeted News ServiceALEXANDRIA, Va., July 24 Noven Pharmaceuticals, Miami, has been assigned a patent (8,784,874) developed by Robert C. Strauss, Miami, for a "multi-layer transdermal drug delivery device."The patent application was filed on Sept. ... [Published Pharmacy Choice - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Researchers Submit Patent Application, "Multi-Polymer Compositions for Transdermal Drug Delivery", for Approval

By a News Reporter-Staff News Editor at Biotech Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Kulakofsky, Joshua (Miami, FL); LlU, Puchun (Miami, FL), filed on December 27, 2013, was made available online ... [Published Pharmacy Choice - Jul 23 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

ADHD Drugs Not Tested for Safety, Efficacy Over Time

Studies supporting the approval of the majority of drugs used to treat attention-deficit/hyperactivity disorder (ADHD) in children were not designed to demonstrate long-term safety and efficacy of the drugs or detect rare adverse events (AEs), new research ... [Published Diabetes Care - Jul 17 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Highlights of EMA Pharmacovigilance committee July meeting

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) concluded two safety reviews and gave a recommendation as part of a regular benefit-risk assessment review of a medicine at its July meeting.Recommendation for oral methadone ... [Published Pharma Letter - Jul 14 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Study: Weight loss could cool hot flashes

Published: Tuesday, 7/8/2014Symptom of menopause has few treatment optionsBY CAMPBELL NORTHBLOCK NEWS ALLIANCEPITTSBURGH — Researchers are still unsure what causes 70 percent of menopausal women to experience the sudden and prickling heat of a hot fl ... [Published Toledoblade.com - Jul 08 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 2 reports

Noven Appoints Krista Roberts as Vice President of Operations

MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced the appointment of Krista Roberts as the company's new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, ... [Published FierceBiotech - Jun 27 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Noven tap Krista Roberts as VP of Operations

Noven Pharmaceuticals has appointed Krista Roberts as the company's new Vice President of Operations. In the role, Roberts will be responsible for all Noven manufacturing and related operations, reporting to Jeffrey Eisenberg, Noven's President and Chief ... [Published Individual.com - Jun 26 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Risk for Major Malformations Low With Atypical Antipsychotics

HOLLYWOOD, Florida — An evaluation of women exposed to a range of atypical antipsychotic medications during pregnancy has found that the risk for major malformations in their offspring was very low and virtually identical with that of women who were ... [Published General Medicine eJournal - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 5 reports

Noven Pharmaceuticals Inc. Appoints As Vice President Of Operations

6/23/2014 8:50:55 AMNoven Pharmaceuticals, Inc. today announced the appointment of Krista Roberts as the company’s new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, reporting ... [Published BioSpace - Jun 23 2014]
First reported Apr 16 2014 - Updated Apr 17 2014 - 1 reports

Noven Announces Settlement of Lidoderm® Patent Litigation

MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related ... [Published Business Wire Health News - Apr 16 2014]
First reported Mar 25 2014 - Updated Mar 27 2014 - 3 reports

Noven Pharma's Brisdelle receives US patent to treat VMS associated with menopause

The US Patent and Trademark Office (USPTO) has issued US patent No. 8,658,663, entitled “method of treating thermoregulatory dysfunction with paroxetine” to Noven Pharmaceuticals, Inc. This method of use patent covers the company’s Brisdelle (paroxetine) ... [Published PharmaBiz - Mar 27 2014]
First reported Mar 20 2014 - Updated Mar 21 2014 - 2 reports

Actavis settles generic Daytrana patent litigation with Noven Pharma

Actavis plc,a global, integrated specialty pharmaceutical company, has entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis' generic version of Daytrana (Methylphenidate Transdermal ... [Published PharmaBiz - Mar 21 2014]

Quotes

News editors obtained the following quote from the background information supplied by the inventors: "Many factors influence the design and performance of transdermal drug delivery compositions. These include the individual drugs themselves, the physical and chemical characteristics of the compositions' components and their performance and behavior relative to other components, external and environmental conditions during manufacturing and storage, properties of the application site, the desired rate of drug delivery and therapeutic onset, the desired drug delivery profile, and the intended duration of delivery, among others."
"Most of the medications that we are talking about for ADHD have been studied long term and extensively in children" Dr. Robb insisted

More Content

All (25) | News (16) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Noven Pharmaceuticals Assigned Patent for Multi... [Published Pharmacy Choice - Jul 24 2014]
Researchers Submit Patent Application, "Multi-P... [Published Pharmacy Choice - Jul 23 2014]
ADHD Drugs Not Tested for Safety, Efficacy Over... [Published Diabetes Care - Jul 17 2014]
Highlights of EMA Pharmacovigilance committee J... [Published Pharma Letter - Jul 14 2014]
Study: Weight loss could cool hot flashes [Published Toledoblade.com - Jul 08 2014]
Noven Appoints Krista Roberts as Vice President... [Published FierceBiotech - Jun 27 2014]
Noven Pharmaceuticals appoints vice president o... [Published Individual.com - Jun 27 2014]
Noven tap Krista Roberts as VP of Operations [Published Individual.com - Jun 26 2014]
Risk for Major Malformations Low With Atypical ... [Published General Medicine eJournal - Jun 24 2014]
Noven Pharmaceuticals Inc. Appoints As Vice Pre... [Published BioSpace - Jun 23 2014]
Noven Appoints Krista Roberts as Vice President... [Published Wall Street Select - Jun 23 2014]
Noven Appoints Krista Roberts as Vice President... [Published Business Wire Health News - Jun 23 2014]
Noven Appoints Krista Roberts as Vice President... [Published Business Wire Photo/Multimedia News - Jun 23 2014]
Noven Appoints Krista Roberts as Vice President... [Published Business Wire News with Multimedia - Jun 23 2014]
Noven Announces Settlement of Lidoderm® Patent ... [Published Business Wire Health News - Apr 16 2014]
Noven Pharma's Brisdelle receives US patent to ... [Published PharmaBiz - Mar 27 2014]
Noven Pharmaceuticals announces issuance of new... [Published PBR - News - Mar 26 2014]
Noven Pharmaceuticals Announces Issuance of New... [Published PR Newswire: Policy & Public Interest - Mar 25 2014]
Actavis settles generic Daytrana patent litigat... [Published PharmaBiz - Mar 21 2014]
Actavis to settle patent litigation of Daytrana... [Published Pharmaceutical Business Review - Mar 20 2014]
Actavis Announces Daytrana® Patent Challenge Se... [Published PR Newswire: Policy & Public Interest - Mar 19 2014]
Compliance Congress: Walking the Line [Published Pharmaceutical Executive - Feb 06 2014]
Court Report - Part II [Published Patent Docs - Feb 04 2014]
Noven Pharma inks pact with Shionogi to co-prom... [Published PharmaBiz - Jan 15 2014]
First and Only FDA-Approved, Non-Hormonal Treat... [Published PR Newswire - Nov 05 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Noven Appoints Krista Roberts as Vice President... [Published Business Wire Health News - Jun 23 2014]
MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced the appointment of Krista Roberts as the company’s new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, ...
Noven Appoints Krista Roberts as Vice President... [Published Business Wire Photo/Multimedia News - Jun 23 2014]
MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced the appointment of Krista Roberts as the company’s new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, ...
Noven Appoints Krista Roberts as Vice President... [Published Business Wire News with Multimedia - Jun 23 2014]
MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced the appointment of Krista Roberts as the company’s new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, ...
Noven Announces Settlement of Lidoderm® Patent ... [Published Business Wire Health News - Apr 16 2014]
MIAMI & NEW YORK--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related ...
Noven Pharmaceuticals announces issuance of new... [Published PBR - News - Mar 26 2014]
Noven Pharmaceuticals has announced that the US Patent and Trademark Office has issued US Patent No. 8,658,663, entitled ‘Method Of Treating Thermoregulatory Dysfunction With Paroxetine’. ...
1 2

Press Releases

sort by: Date | Relevance
First and Only FDA-Approved, Non-Hormonal Treat... [Published PR Newswire - Nov 05 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.